MedTrace Logo

Novartis - Closing the Gap in Cardiovascular Risk: Engage, Empower, Evaluate

NCT06027905 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 445

Last updated 2025-09-17

No results posted yet for this study

Summary

This study aims to decrease the racial gap in high blood pressure in African American and Latinx patients in Rush University Medical Center clinics.

Conditions

Interventions

OTHER

E3 Remote Monitoring and Social Intervention

Patients are enrolled in a 12 week remote blood pressure monitoring program composed of a community health worker, nurse, pharmacist and social worker. Participants will receive a home cellular blood pressure cuff for remote monitoring and will receive tele-health calls from their community health worker to assist with blood pressure taking technique and adherence, medication adherence, education around diet and activity. Social work is available to provide institutional and community resources to patients with social needs. Patients will be screened pre intervention and post intervention for medication adherence and social determinants of health needs. The team nurse monitors and triages home blood pressures on the remote portal. The pharmacist assists with medication reconciliation, adherence, and titration of medications according to standards or care.

Sponsors & Collaborators

Principal Investigators

  • David A Ansell, MD, MPH · Rush University Medical Center

  • Laura J Zimmermann, MD · Rush University Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-13
Primary Completion
2024-11-01
Completion
2025-05-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06027905 on ClinicalTrials.gov